XP vs HLI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
XP · XP Inc$13.13 ▼ 4.02%
HLI · Houlihan Lokey$132.07 ▼ 2.68%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- XP -24.4%
- HLI -22.1%
Head to head
| Metric | XP | HLI |
|---|---|---|
| Price | $13.13 | $132.07 |
| Change today | ▼ 4.02% | ▼ 2.68% |
| Market cap | $6.51B | $9.17B |
| Return, 3 months | -23.1% | +3.0% |
| Return, year to date | -18.8% | -23.1% |
| Return, 1 year | -22.7% | -22.6% |
| P/E (TTM) | 7.5 | 22.2 |
| P/B | 1.5 | 4.0 |
| P/E percentile vs own 5y | 5th | 39th |
| Dividend yield | 2.98% | 1.97% |
| Revenue growth (YoY, latest qtr) | +9.7% | +4.8% |
| Net profit growth (YoY) | +4.8% | -0.9% |
| Gross margin | 27.6% | 38.5% |
| Operating margin | -55.6% | 22.8% |
| Net margin | 63.1% | 15.8% |
| Return on equity | 22.6% | 17.7% |
| Analyst target vs. price | +104.7% | +21.5% |
| Analyst buy share | 63% | 75% |
| RSI (14) | 30 | 40 |
| 30-day volatility | 196.1% | 39.7% |
| Max drawdown, 1 year | -59.7% | -35.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HLI is the largest of the group by market value.
- HLI has returned the most over the past year.
- XP carries the lowest trailing P/E.
- XP pays the highest dividend yield.
- XP is growing revenue fastest.
- XP keeps the most profit per dollar of sales.
- HLI has been the calmest stock over the last 30 days.